Which drugs are associated with the treatment of breast cancer according to the recent FDA drug approvals?

The drugs associated with the treatment of breast cancer according to recent FDA drug approvals include fam-trastuzumab deruxtecan-nxki (Enhertu) and abemaciclib, among others.

Recent FDA drug approvals for breast cancer treatment include fam-trastuzumab deruxtecan-nxki, which is marketed as Enhertu, and abemaciclib. Other notable drugs listed for breast cancer treatment are ado-trastuzumab, alpelisib, anastrozole, capecitabine, cyclophosphamide, DOCEtaxel, DOXOrubicin, epirubicin, eribulin, fulvestrant, gemcitabine, lapatinib, letrozole, neratinib, paclitaxel, palbociclib, ribociclib, tamoxifen, and trastuzumab.